Aspirin/Caffeine/Acetaminophen

阿司匹林/咖啡因/对乙酰氨基酚

Report date: 2026/05/12 20:00:17

Base Information

Drug NameAspirin/Caffeine/Acetaminophen
Drug Alias Name复方对乙酰氨基酚Paracetamol, Caffeine and Aspirin Tablets氨酚咖匹林片Pediatric Paracetamol，Aspirin and Caffeine Tablets阿司匹林/咖啡因/扑热息痛 +[8] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsCyclooxygenasesAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsHeadacheBack PainDysmenorrhea +[8] 
Global Approved IndicationsMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China
CombinationsYes AspirinCaffeineAcetaminophen
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHaleon PLCTaizhou Overseas Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsHeadacheBack PainDysmenorrhea +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN01
Related LinksN/A